1
|
Cao M, Luo Y, Wu Z, Mazzola CA, Catania L, Alvarez TL, Halperin JM, Biswal B, Li X. Topological Aberrance of Structural Brain Network Provides Quantitative Substrates of Post-Traumatic Brain Injury Attention Deficits in Children. Brain Connect 2021; 11:651-662. [PMID: 33765837 DOI: 10.1089/brain.2020.0866] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Background: Traumatic brain injury (TBI)-induced attention deficits are among the most common long-term cognitive consequences in children. Most of the existing studies attempting to understand the neuropathological underpinnings of cognitive and behavioral impairments in TBI have utilized heterogeneous samples and resulted in inconsistent findings. The current research proposed to investigate topological properties of the structural brain network in children with TBI and their relationship with post-TBI attention problems in a more homogeneous subgroup of children who had severe post-TBI attention deficits (TBI-A). Materials and Methods: A total of 31 children with TBI-A and 35 group-matched controls were involved in the study. Diffusion tensor imaging-based probabilistic tractography and graph theoretical techniques were used to construct the structural brain network in each subject. Network topological properties were calculated in both global level and regional (nodal) level. Between-group comparisons among the topological network measures and analyses for searching brain-behavioral were all corrected for multiple comparisons using Bonferroni method. Results: Compared with controls, the TBI-A group showed significantly higher nodal local efficiency and nodal clustering coefficient in left inferior frontal gyrus and right transverse temporal gyrus, whereas significantly lower nodal clustering coefficient in left supramarginal gyrus and lower nodal local efficiency in left parahippocampal gyrus. The temporal lobe topological alterations were significantly associated with the post-TBI inattentive and hyperactive symptoms in the TBI-A group. Conclusion: The results suggest that TBI-related structural re-modularity in the white matter subnetworks associated with temporal lobe may play a critical role in the onset of severe post-TBI attention deficits in children. These findings provide valuable input for understanding the neurobiological substrates of post-TBI attention deficits, and have the potential to serve as quantitatively measurable criteria guiding the development of more timely and tailored strategies for diagnoses and treatments to the affected individuals. Impact statement This study provides a new insight into the neurobiological substrates associated with post-traumatic brain injury attention deficits (TBI-A) in children, by evaluating topological alterations of the structural brain network. The results demonstrated that relative to group-matched controls, the children with TBI-A had significantly altered nodal local efficiency and nodal clustering coefficient in temporal lobe, which strongly linked to elevated inattentive and hyperactive symptoms in the TBI-A group. These findings suggested that white matter structural re-modularity in subnetworks associated with temporal lobe may serve as quantitatively measurable biomarkers for early prediction and diagnosis of post-TBI attention deficits in children.
Collapse
Affiliation(s)
- Meng Cao
- Department of Biomedical Engineering and New Jersey Institute of Technology, Newark, New Jersey, USA
| | - Yuyang Luo
- Department of Biomedical Engineering and New Jersey Institute of Technology, Newark, New Jersey, USA
| | - Ziyan Wu
- Department of Electrical and Computer Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA
| | | | - Lori Catania
- North Jersey Neurodevelopmental Center, North Haledon, New Jersey, USA
| | - Tara L Alvarez
- Department of Biomedical Engineering and New Jersey Institute of Technology, Newark, New Jersey, USA
| | - Jeffrey M Halperin
- Department of Psychology, Queens College, City University of New York, New York, New York, USA
| | - Bharat Biswal
- Department of Biomedical Engineering and New Jersey Institute of Technology, Newark, New Jersey, USA
| | - Xiaobo Li
- Department of Biomedical Engineering and New Jersey Institute of Technology, Newark, New Jersey, USA.,Department of Electrical and Computer Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA
| |
Collapse
|
3
|
Richard F, Ahmed W, Denholm N, Dawson A, Varol N, Essén B, Johnsdotter S, Bukuluki P, Ahmed W, Naeema AGH, eltayeb D, Shell-Duncan B, Njue C, Muteshi J, Lamy C, Neyrinck P, Richard F, Verduyckt P, Alexander S, Kimani S, Esho T, Kimani V, Kigondu C, Karanja J, Guyo J, Touré M, Guindo YG, Samaké D, Camara L, Traoré Y, Traoré AA, Samaké A, Johnson-Agbakwu CE, Jordal M, Jirovsky E, Wu S, Fitzgerald K, Mishori R, Reingold R, Ismail EA, Say L, Uebelhart M, Boulvain M, Dallenbäch P, Irion O, Petignat P, Abdulcadir J, Farina P, Leye E, Ortensi L, Pecorella C, Novak L, Abdulcadir J, Cuzin B, Delmas FB, Papingui A, Bader D, Wahlberg A, Johnsdotter S, Selling KE, Källestål C, Essén B, Ibraheim AHHI, Elawad NAM, Ahmed W, Gasseer A, Naeema H, Maison E, Hussein H, Albagir AM, Bukuluki P, Albirair MT, Salih SAS, Ahmed W, Gasseer A, Naeema H, Maison E, Hussein H, Albagir AM, Albirair MT, Bukuluki P, Dawson A, Varol N, Esho T, Kimani S, Kimani V, Muniu S, Kigondu C, Nyamongo I, Guyo J, Ndavi P, Reingold R, Mishori R, Fitzgerald K, Wu S, Hedley H, Kuenzi R, Malavé-Seda L, Clare C, Greenfield J, Augustus P, Ukatu N, Manu E, Altonen B, Caillet M, Richard F, Foldès P, Cuzin B, Delmas FB, Papingui A, Wylomanski S, Vital M, De Visme S, Dugast S, Hanf M, Winer N, Johnsdotter S, Essén B, Seifeldin A, Mishori R, Fitzgerald K, Reingold R, Wu S, Villani M, Johnsdotter S, Essén B, Seinfeld R, Earp B, Cappon S, L’Ecluse C, Clays E, Tency I, Leye E, Johansen RE, Ouédraogo CM, Madzou S, Simporé A, Combaud V, Ouattara A, Millogo F, Ouédraogo A, Kiemtore S, Zamane H, Sawadogo YA, Kaien P, Dramé B, Thieba B, Lankoandé J, Descamps P, Catania L, Mastrullo R, Caselli A, Cecere R, Abdulcadir O, Abdulcadir J, Vogt S, Efferson C, O’Neill S, Dubour D, Florquin S, Bos M, Zewolde S, Richard F, Varol N, Dawson A, Turkmani S, Hall JJ, Nanayakkara S, Jenkins G, Homer CS, McGeechan K, Vital M, de Visme S, Hanf M, Philippe HJ, Winer N, Wylomanski S, Johnson-Agbakwu C, Warren N, Macfarlane A, Dorkenoo W, Lien IL, Schultz JH. Female Genital Mutilation/Cutting: sharing data and experiences to accelerate eradication and improve care: part 2. Reprod Health 2017. [PMCID: PMC5607483 DOI: 10.1186/s12978-017-0362-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
5
|
Waber DP, Queally JT, Catania L, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Sallan SE, Silverman LB. Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis. Pediatr Blood Cancer 2012; 58:758-65. [PMID: 21721112 PMCID: PMC3189432 DOI: 10.1002/pbc.23234] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2011] [Accepted: 05/18/2011] [Indexed: 11/09/2022]
Abstract
BACKGROUND Children treated for acute lymphoblastic leukemia (ALL) as High Risk (HR) patients may be more vulnerable to neurocognitive late effects because of the greater intensity of their therapy. We compared neuropsychological outcomes in children treated for Standard Risk (SR) or HR ALL on Dana-Farber Cancer Institute (DFCI) Consortium ALL Protocol 95-01. We also evaluated their performance relative to normative expectations. PROCEDURE Between 1996 and 2000, 498 children with newly diagnosed ALL were treated on Protocol 95-01, 298 of whom were eligible for neuropsychological follow-up. A feature of this protocol was modification of risk group criteria to treat more children as SR rather than HR patients, intended to minimize toxicities. Testing was completed at a median of 5.3 years post-diagnosis for 211 patients (70.8%; ages 6-25 years; 45.5% male; 40% HR), all of whom were in continuous complete remission. RESULTS Test scores for both groups were generally at or above normative expectation, with the exception of verbal working memory, processing complex visual information, and parent ratings of metacognitive skills. After adjusting for covariates, the SR group performed better on measures of IQ and academic achievement, working memory and visual learning. Effect sizes, however, were only in the small to moderate range. CONCLUSIONS HR patients exhibited neuropsychological deficits relative to SR patients, though the differences were modest in degree. Modification of the risk group criteria to treat more children on the SR protocol therefore likely afforded some benefit in terms of neurocognitive late effects.
Collapse
Affiliation(s)
- Deborah P. Waber
- Division of Psychology, Department of Psychiatry, Children's Hospital Boston; Department of Psychiatry, Harvard Medical School, Boston, MA
| | - Jennifer Turek Queally
- Division of Psychology, Department of Psychiatry, Children's Hospital Boston; Department of Psychiatry, Harvard Medical School, Boston, MA
| | - Lori Catania
- Division of Psychology, Department of Psychiatry, Children's Hospital Boston; Department of Psychiatry, Harvard Medical School, Boston, MA
| | - Philippe Robaey
- Research Center of Ste-Justine Hospital, Department of Psychiatry, University of Montreal, and Children's Hospital of Eastern Ontario, Ottawa
| | | | - Heather Adams
- Division of Child Neurology, University of Rochester Medical Center
| | - Cheryl Alyman
- Division of Pediatric Hematology/Oncology, McMaster University Medical Center, Hamilton, Ontario, Canada
| | - Christine Jandet-Brunet
- Division of Psychology, Department of Pediatric Hematology/Oncology, Centre Hospitalier de l'Université Laval de Québec, Quebec, Canada
| | - Stephen E. Sallan
- Division of Hematology and Oncology, Department of Medicine, Children's Hospital Boston; Department of Pediatric Oncology, Dana Farber Cancer Institute; Department of Pediatrics, Harvard Medical School, Boston, MA
| | - Lewis B. Silverman
- Division of Hematology and Oncology, Department of Medicine, Children's Hospital Boston; Department of Pediatric Oncology, Dana Farber Cancer Institute; Department of Pediatrics, Harvard Medical School, Boston, MA
| |
Collapse
|
10
|
Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 2007; 25:4914-21. [PMID: 17971588 DOI: 10.1200/jco.2007.10.8464] [Citation(s) in RCA: 84] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE We evaluated late neuropsychological toxicity in children treated for standard-risk acute lymphoblastic leukemia (ALL) who were randomly assigned to receive either cranial radiation therapy (CRT) with double intrathecal (IT) chemotherapy or intensive triple IT chemotherapy (no CRT) as CNS-directed therapy. PATIENTS AND METHODS Between 1996 and 2000, 164 children with standard-risk ALL treated on Dana-Farber Cancer Institute Consortium Protocol 95-01 were randomly assigned to receive either 18 Gy CRT delivered in twice daily fractions (0.9 [DOSAGE ERROR CORRECTED] Gy) with double IT therapy (methotrexate and cytarabine) or intensive triple IT drug (methotrexate, cytarabine and hydrocortisone) without CRT. Neuropsychological testing was completed at a median 6 years postdiagnosis for 79 children (CRT, n = 39; triple IT, n = 40), all of whom were in continuous complete remission. RESULTS Cognitive function for both groups was solidly in the average range, with no consistent group differences in basic cognitive skills. Children treated on the CRT plus double IT arm did, however, exhibit less fluent output and were less effective at modulating their behavior by parent report. CONCLUSION This randomized trial revealed only subtle differences 6 years after diagnosis between children who received CNS therapy as CRT plus double IT drug or as intensive triple IT drug. In most situations where comparable therapeutic efficacy can be achieved without CRT, it is preferable to do so. Where therapeutically necessary, however, CRT at lower doses may not add risk for significant neurotoxicity.
Collapse
Affiliation(s)
- Deborah P Waber
- Division of Psychology, Department of Psychiatry, Children's Hospital, Boston, MA 02115, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Waber DP, Silverman LB, Catania L, Mautz W, Rue M, Gelber RD, Levy DE, Goldwasser MA, Adams H, Dufresne A, Metzger V, Romero I, Tarbell NJ, Dalton VK, Sallan SE. Outcomes of a Randomized Trial of Hyperfractionated Cranial Radiation Therapy for Treatment of High-Risk Acute Lymphoblastic Leukemia: Therapeutic Efficacy and Neurotoxicity. J Clin Oncol 2004; 22:2701-7. [PMID: 15226337 DOI: 10.1200/jco.2004.10.173] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Purpose We evaluated 8-year survival and late neuropsychologic toxicity in children with acute lymphoblastic leukemia treated in a randomized clinical trial to test whether hyperfractionated (twice daily) cranial radiation therapy (CRT) can reduce incidence and severity of late toxicities associated with 18 Gy of CRT. Patients and Methods Between 1987 and 1995, 369 children treated on two consecutive Dana-Farber Cancer Institute Consortium protocols for high-risk acute lymphoblastic leukemia were randomly assigned to conventionally fractionated CRT (CFX) or hyperfractionated CRT (HFX) to a total dose of 18 Gy. Neuropsychologic testing was completed for 125 of 287 children in continuous complete remission. Event-free and overall survival, as well as neuropsychologic function, were compared for the two arms of the protocol. Results Eight-year event-free survival (± SE) was 80% ± 3% for children randomly assigned to CFX and 72% ± 3% for HFX (P = .06). Overall survival was 85% ± 3% for CFX and 78% ± 3% for HFX (P = .06). CNS relapses occurred in 2.8% of patients receiving CFX and 2.7% receiving HFX (P = .99). Cognitive function for both groups was solidly in the average range, with no group differences in intelligence, academic achievement, visuospatial reasoning, or verbal learning. Children on the HFX arm exhibited a modest advantage for visual memory (P < .05). Conclusion HFX provides no benefit in terms of cognitive late effects and may compromise antileukemic efficacy. HFX should not be substituted for conventionally dosed CRT in children who require radiation therapy for treatment of acute lymphoblastic leukemia.
Collapse
Affiliation(s)
- Deborah P Waber
- Department of Psychiatry, Children's Hospital and harvard Medical School, Boston, MA 02115, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|